{ "cik": 879407, "cik_padded": "0000879407", "entityName": "ARROWHEAD PHARMACEUTICALS, INC.", "fiscal_years": [ { "accn": "0000879407-25-000029", "filed": "2025-11-25", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 22666000.0, "eps_diluted": -0.01, "free_cash_flow": 156886000.0, "net_income": -1631000.0, "operating_cash_flow": 179552000.0, "operating_income": 98346000.0, "revenue": 829448000.0, "stockholders_equity": 466052000.0, "total_assets": 1385295000.0 }, "period_end": "2025-09-30", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -0.001966367994135859, "operating_margin": 0.11856801149680268, "revenue_growth_yoy": 232.5815263306111, "roa_avg2y": -0.0012918315613221988, "roa_period_end": -0.0011773665536943395, "roe_avg2y": -0.005006937878359959, "roe_period_end": -0.003499609485636796 } }, { "accn": "0000879407-25-000029", "filed": "2025-11-25", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 141469000.0, "eps_diluted": -5.0, "free_cash_flow": -604320000.0, "net_income": -599493000.0, "operating_cash_flow": -462851000.0, "operating_income": -601080000.0, "revenue": 3551000.0, "stockholders_equity": 185444000.0, "total_assets": 1139802000.0 }, "period_end": "2024-09-30", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": -0.985249340561198, "roa_avg2y": -0.6292720407861216, "roa_period_end": -0.5259624039964836, "roe_avg2y": -2.624825137317831, "roe_period_end": -3.232744116822329 } }, { "accn": "0000879407-25-000029", "filed": "2025-11-25", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 176737000.0, "eps_diluted": -1.92, "free_cash_flow": -330627000.0, "net_income": -205275000.0, "operating_cash_flow": -153890000.0, "operating_income": -205002000.0, "revenue": 240735000.0, "stockholders_equity": 271343000.0, "total_assets": 765552000.0 }, "period_end": "2023-09-30", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -0.8527011028724532, "operating_margin": -0.8515670758302698, "revenue_growth_yoy": -0.01026184984644227, "roa_avg2y": -0.28168269992747813, "roa_period_end": -0.26813985202834034, "roe_avg2y": -0.6128865156009512, "roe_period_end": -0.7565148170396878 } }, { "accn": "0001628280-24-049277", "filed": "2024-11-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 52777000.0, "eps_diluted": -1.67, "free_cash_flow": -188908000.0, "net_income": -176063000.0, "operating_cash_flow": -136131000.0, "operating_income": -178507000.0, "revenue": 243231000.0, "stockholders_equity": 398520000.0, "total_assets": 691939000.0 }, "period_end": "2022-09-30", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -0.7238509893886881, "operating_margin": -0.7338990506966628, "revenue_growth_yoy": 0.7588855062297974, "roa_avg2y": -0.2511441872009369, "roa_period_end": -0.25444873030715137, "roe_avg2y": -0.436154690329501, "roe_period_end": -0.4417921308842718 } }, { "accn": "0001628280-23-040219", "filed": "2023-11-29", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 23567000.0, "eps_diluted": -1.36, "free_cash_flow": 147745000.0, "net_income": -140848000.0, "operating_cash_flow": 171312000.0, "operating_income": -149036000.0, "revenue": 138287000.0, "stockholders_equity": 408822000.0, "total_assets": 710148000.0 }, "period_end": "2021-09-30", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -1.0185194559141495, "operating_margin": -1.077729649207807, "revenue_growth_yoy": 0.5715860532775707, "roa_avg2y": -0.2285284086668419, "roa_period_end": -0.1983361214845356, "roe_avg2y": -0.32356493650872026, "roe_period_end": -0.34452157662748095 } }, { "accn": "0001628280-22-030869", "filed": "2022-11-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 11952000.0, "eps_diluted": -0.84, "free_cash_flow": -107753000.0, "net_income": -84553000.0, "operating_cash_flow": -95801000.0, "operating_income": -93159000.0, "revenue": 87992000.0, "stockholders_equity": 461779132.0, "total_assets": 522504000.0 }, "period_end": "2020-09-30", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -0.9609169015365033, "operating_margin": -1.058721247386126, "revenue_growth_yoy": -0.47870802625654635, "roa_avg2y": -0.19385121698657096, "roa_period_end": -0.16182268461102686, "roe_avg2y": -0.23940125297292256, "roe_period_end": -0.18310268728210957 } }, { "accn": "0001564590-21-057888", "filed": "2021-11-22", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 12001000.0, "eps_diluted": 0.69, "free_cash_flow": 161034000.0, "net_income": 67975000.0, "operating_cash_flow": 173035000.0, "operating_income": 61191000.0, "revenue": 168796000.0, "stockholders_equity": 244591440.0, "total_assets": 349845437.0 }, "period_end": "2019-09-30", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": 0.40270504040380106, "operating_margin": 0.36251451456195644, "revenue_growth_yoy": 9.456736673741032, "roa_avg2y": 0.29461136121786924, "roa_period_end": 0.1943000902995914, "roe_avg2y": 0.39939759385321255, "roe_period_end": 0.2779124240815623 } }, { "accn": "0001564590-20-054893", "filed": "2020-11-23", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 1421252.0, "eps_diluted": -0.65, "free_cash_flow": -48644669.0, "net_income": -54450478.0, "operating_cash_flow": -47223417.0, "operating_income": -55936235.0, "revenue": 16142321.0, "stockholders_equity": 95796189.0, "total_assets": 111609951.0 }, "period_end": "2018-09-30", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": -0.48603952615582374, "roa_avg2y": -0.5050309756336937, "roa_period_end": -0.4878640077532155, "roe_avg2y": -0.6145009241950696, "roe_period_end": -0.5683992084486785 } }, { "accn": "0001564590-19-044376", "filed": "2019-11-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 7918198.0, "eps_diluted": -0.47, "free_cash_flow": -31857170.0, "net_income": -34380295.0, "operating_cash_flow": -23938972.0, "operating_income": -36995909.0, "revenue": 31407709.0, "stockholders_equity": 81422350.0, "total_assets": 104022280.0 }, "period_end": "2017-09-30", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -1.0946451076708588, "operating_margin": -1.1779244707087677, "roa_avg2y": -0.2961281214283701, "roa_period_end": -0.3305089544278399, "roe_avg2y": -0.3884739656061232, "roe_period_end": -0.42224641023011494 } }, { "accn": "0001564590-18-030805", "filed": "2018-12-11", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 3860237.0, "free_cash_flow": -68287723.0, "net_income": -81723002.0, "operating_cash_flow": -64427486.0, "operating_income": -81742726.0, "stockholders_equity": 95579447.0, "total_assets": 128176505.0 }, "period_end": "2016-09-30", "ratio_units": { "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_period_end": -0.6375817627419316, "roe_period_end": -0.8550269390029009 } }, { "accn": "0001193125-11-347334", "filed": "2011-12-20", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.4 }, "period_end": "2011-09-30", "ratios": {} } ], "latest_filing": { "accn": "0000879407-25-000029", "filed": "2025-11-25", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000879407.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000879407.json" }, "ticker": "ARWR" }